GI Alliance - Glenview

Glenview, Illinois 60026

3 studies enrolling now · 4 studies all time

What they study most

Celiac Disease, Crohn's Disease, Eosinophilic Esophagitis, Ulcerative Colitis

Studies at this site

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• Study of DONQ52 in Active Celiac Disease — Recruiting now
• A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting — Recruiting now
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) — Completed